Colleen M Cunningham
Colleen M Cunningham
Assistant Professor of Entrepreneurship & Strategy, University of Utah Eccles School of Business
Verified email at
Cited by
Cited by
Killer acquisitions
C Cunningham, F Ederer, S Ma
Journal of Political Economy 129 (3), 649-702, 2021
The cost of drug development: a systematic review
S Morgan, P Grootendorst, J Lexchin, C Cunningham, D Greyson
Health policy 100 (1), 4-17, 2011
Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guideline cautions against long-term use
CM Cunningham, GE Hanley, S Morgan
Health policy 97 (2-3), 122-129, 2010
Racial and ethnic disparities in the use of antipsychotic medication: a systematic review and meta-analysis
JH Puyat, JR Daw, CM Cunningham, MR Law, ST Wong, DL Greyson, ...
Social psychiatry and psychiatric epidemiology 48, 1861-1872, 2013
Population aging and the determinants of healthcare expenditures: the case of hospital, medical and pharmaceutical care in British Columbia, 1996 to 2006
S Morgan, C Cunningham
Healthcare Policy 7 (1), 68-79, 2011
Ethnic differences in the use of prescription drugs: a cross-sectional analysis of linked survey and administrative data
S Morgan, G Hanley, C Cunningham, H Quan
Open Medicine 5 (2), e87, 2011
The limits of relational governance: Sales force strategies in the US medical device industry
AK Chatterji, CM Cunningham, JE Joseph
Strategic Management Journal, 2018
Information behaviour of Canadian pharmaceutical policy makers
DL Greyson, C Cunningham, S Morgan
Health Information & Libraries Journal 29 (1), 16-27, 2012
Individual and contextual determinants of regional variation in prescription drug use: an analysis of administrative data from British Columbia
SG Morgan, CM Cunningham, GE Hanley
PLoS One 5 (12), e15883, 2010
The British Columbia Rx Atlas
S Morgan, C Cunningham, G Hanley, D Mooney
University of British Columbia. Centre for Health Services and Policy Research, 2009
Income inequities in end-of-life health care spending in British Columbia, Canada: a cross-sectional analysis, 2004-2006
CM Cunningham, GE Hanley, SG Morgan
International journal for equity in health 10, 1-9, 2011
Inventive capabilities in the division of innovative labor
A Arora, WM Cohen, CM Cunningham
National Bureau of Economic Research, 2018
Drug development: innovation or imitation deficit?
SG Morgan, CM Cunningham, MR Law
Bmj 345, 2012
The effect of evidence-based drug coverage policies on pharmaceutical R&D: a case study from British Columbia
S Morgan, C Cunningham
Healthcare Policy 3 (3), e128, 2008
Ethnic disparities in antipsychotic drug use in British Columbia: a cross-sectional retrospective study
JH Puyat, GE Hanley, CM Cunningham, MR Law, ST Wong, ...
Psychiatric Services, 2011
When does novelty pay?
CM Cunningham
Academy of Management Proceedings 2017 (1), 16957, 2017
Corporate proximity and product market reentry: The role of corporate headquarters in business unit response to product failure
CM Kim, C Cunningham, J Joseph
Academy of Management Journal 66 (4), 1209-1232, 2023
Listening for prescriptions: a national consultation on pharmaceutical policy issues
S Morgan, CM Cunningham
Healthcare Policy 6 (2), 48, 2010
Regulatory uncertainty and firm response in the US electricity industry
N Dutt, CM Cunningham
Academy of Management Proceedings 2015 (1), 13490, 2015
Advanced technology and creative magic: How technology use shapes the creativity-innovation process
C Cunningham, H Lifshitz-Assaf, E Truelove, A Vardanyan
Academy of Management Proceedings 2020 (1), 13851, 2020
The system can't perform the operation now. Try again later.
Articles 1–20